Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters, +22

New England Journal of Medicine

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, +777

The Lancet

Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2 +4

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, +26

New England Journal of Medicine

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

Justin A. Ezekowitz, Eileen O’Meara, Michael McDonald, +32

Canadian Journal of Cardiology

Heart FailureCardiovascular DiseaseHealth PolicyCardiac CarePreventive Cardiology +4

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters, +21

European Heart Journal

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, +1117

Journal of the American Heart Association

Platelet Membrane Receptor Glycoprotein IIb/IIIa Antagonism in Unstable Angina

Pierre Roux, Simon Kouz, Louis Roy, +12

Circulation

Effects of Ramipril on Coronary Events in High-Risk Persons

Gilles R. Dagenais, Salim Yusuf, Martial G. Bourassa, +5

Circulation

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

Jean‐Claude Tardif, Philippe L. L’Allier, Réda Ibrahim, +9

Circulation Cardiovascular Imaging

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz, +709

Queensland's institutional digital repository (The University of Queensland)

Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials +8